aod9604 weight loss evidence clinical trials Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment Is AOD 9604 (Anti-Obesity Drug)

Gradual introduction: Starting with a lower dose and gradually increasing over several weeks allows the digestive system to adapt, potentially reducing initial side effects

Infants are particularly sensitive to b12 deficiency and low levels may result in stunted brain growth (R)

Lead Researcher Spotlight Professor Frank Ng, PhD Department of Biochemistry and Molecular Biology Monash University, Melbourne, Australia Professor Frank Ng led the pioneering research team that developed AOD-9604 in the 1990s as part of efforts to create a targeted anti-obesity therapeutic derived from human growth hormone

Contact us today